Riskpilot← Back to searchSign inGet full accessBodyRestart KBH ApS
APSActiveCVR 32761194Tordenskjoldsgade 21, 1. thOther human health activities n.e.c. · NACE 8699Est. 20092 employeeswww.bodyrestart.dk
Revenue 2024
DKK 681K
+11% vs 2023
EBITDA margin
4.7%
+147% vs 2023
Equity ratio
83.6%
Financial strength
Net profit 2024
DKK 24K
+142% vs 2023
| Revenue | DKK 681K | +11% |
| EBITDA | DKK 32K | +147% |
| Net profit | DKK 24K | +142% |
| Total assets | DKK 191K | +3% |
| Equity | DKK 159K | +17% |
| Employees | 2 | — |
Legal name
BodyRestart KBH ApS
CVR number
32761194
Legal form
Anpartsselskab
NACE code
8699 · Other human health activities n.e.c.
Founded
2. december 2009
Share capital
DKK 125.000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør i forening med et bestyrelsesmedlem, to bestyrelsesmedlemmer i forening, eller af bestyrelsesformanden alene.
Company purpose
Selskabets formål er at drive virksomhed inden for behandling samt enhver i forbindelse hermed forbundet virksomhed.
Address
Tordenskjoldsgade 21, 1. th
Phone
+4529938099
Email
info@bodyrestart.dk
Website
www.bodyrestart.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 896 | 886 | 677 | 612 | 681 |
| Staff expenses | -861 | -814 | -756 | -680 | -648 |
| EBITDA | 34 | 72 | -79 | -69 | 32 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | 34 | 72 | -79 | -69 | 32 |
| Net financials | 0 | -3 | -2 | -1 | -1 |
| Profit before tax | 35 | 70 | -81 | -70 | 32 |
| Tax | 7 | 16 | -18 | -14 | 8 |
| Net profit | 28 | 54 | -63 | -56 | 24 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 352 | 315 | 251 | 185 | 191 |
| Equity | 202 | 255 | 192 | 136 | 159 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 150 | 60 | 59 | 49 | 31 |
| Total debt | 150 | 60 | 59 | 49 | 31 |
EBITDA margin
4.7%
This company
15.8%
Market median
-70% vs market
20202024
Equity ratio
83.6%
This company
38.2%
Market median
+119% vs market
20202024
Return on equity
14.8%
This company
18.4%
Market median
+20% vs market
20202024
Net profit margin
3.5%
This company
8.1%
Market median
-57% vs market
20202024
Asset turnover
3.57×
This company
1.12×
Market median
+219% vs market
20202024
Debt / equity
0.20×
This company
0.62×
Market median
+68% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MJ Chief Executive Officer | Chief Executive Officer | 2019 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2019 | |
| Former (2) | ||
| Chairman | 2009 – 2014 | |
| Board of Directors | 2009 – 2014 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 50–66.65% | 50–66.65% | 2018 | |
| Company | 50–66.65% | 50–66.65% | 2018 | |
| Company | 33.33–49.99% | 33.33% | 2019 | |
| Individual | 33.33–49.99% | 33.33% | 2018 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
ETZERODT ApS
BodyRestart KBH ApS Board members of BodyRestart KBH ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Michael John Etzerodt | Chief Executive Officer | 0 companies |
| Morten Lambæk Jensen | Chairman | 0 companies |
| Mogens Michael Berggren | Board of Directors | 0 companies |
| Per Mikkel Strøm Poulsen | Chairman | 0 companies |